{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:49:58Z","timestamp":1779936598275,"version":"3.53.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To characterize the trend of opioid use (number of users, dispensations and oral morphine milligram equivalents) in Catalonia (Spain).<\/jats:p><jats:p><jats:bold>Design, setting, and participants:<\/jats:bold> This population-based cohort study included all individuals aged 18 years or older, registered in the Information System for Research in Primary Care (SIDIAP), which covers &amp;gt;75% of the population in Catalonia, Spain, from 1 January 2007, to 31 December 2019.<\/jats:p><jats:p><jats:bold>Main exposure and outcomes:<\/jats:bold> The exposures were all commercialized opioids and their combinations (ATC-codes): codeine, tramadol, oxycodone, tapentadol, fentanyl, morphine, and other opioids (dihydrocodeine, hydromorphone, dextropropoxyphene, buprenorphine, pethidine, pentazocine). The main outcomes were the annual figures per 1,000 individuals of 1) opioid users, 2) dispensations, and 3) oral morphine milligram equivalents (MME). Results were stratified separately by opioid types, age (5-year age groups), sex (male or female), living area (rural or urban), and socioeconomic status (from least, U1, to most deprived, U5). The overall trends were quantified using the percentage change (PC) between 2007 and 2019.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among 4,656,197 and 4,798,114 residents from 2007 to 2019, the number of opioid users, dispensations and morphine milligram equivalents per 1,000 individuals increased 12% (percentage change: 95% confidence interval (CI) 11.9\u201312.3%), 105% (95% confidence interval 83%\u2013126%) and 339% (95% CI 289%\u2013390%) respectively. Tramadol represented the majority of opioid use in 2019 (61, 59, and 54% of opioid users, dispensations, and total MME, respectively). Individuals aged 80 years or over reported the sharpest increase regarding opioid users (PC: 162%), dispensations (PC: 424%), and MME (PC: 830%). Strong opioids were increasingly prescribed for non-cancer pains over the years.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Despite the modest increase of opioid users, opioid dispensations and MME increased substantially, particularly in the older population. In addition, strong opioids were incrementally indicated for non-cancer pains over the years. These findings suggest a transition of opioid prescriptions from intermittent to chronic and weak to strong and call for more rigorous opioid stewardship.<\/jats:p>","DOI":"10.3389\/fphar.2022.912361","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T06:07:49Z","timestamp":1654668469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Trends of Dispensed Opioids in Catalonia, Spain, 2007\u201319: A Population-Based Cohort Study of Over 5 Million Individuals"],"prefix":"10.3389","volume":"13","author":[{"given":"Junqing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Y.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Delmestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Turkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlen","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"B1","unstructured":"Real Decreto 1675\/2012, de 14 de diciembre, por el que se regulan las recetas oficiales y los requisitos especiales de prescripci\u00f3n y dispensaci\u00f3n de estupefacientes para uso humano y veterinario2020"},{"key":"B2","unstructured":"WHO Analgesic Ladder\n            AnekarA. A.\n            CascellaM.\n          2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00198-019-05181-6","article-title":"Impact of Risk Minimisation Measures on the Use of Strontium Ranelate in Europe: A Multi-National Cohort Study in 5 EU Countries by the EU-ADR Alliance","volume":"31","author":"Berencsi","year":"2020","journal-title":"Osteoporos. Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ejp.1337","article-title":"Trends in the Consumption of Opioids for the Treatment of Severe Pain in Europe, 1990-2016","volume":"23","author":"Bosetti","year":"2019","journal-title":"Eur. J. Pain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","article-title":"Opioid Prescribing Trends and Geographical Variation in England, 1998-2018: A Retrospective Database Study","volume":"6","author":"Curtis","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s002280050693","article-title":"Opioid Consumption in Spain - the Significance of a Regulatory Measure","volume":"55","author":"del Pozo","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1157\/13123961","article-title":"Construcci\u00f3n de un \u00edndice de privaci\u00f3n a partir de datos censales en grandes ciudades espa\u00f1olas (Proyecto MEDEA)","volume":"22","author":"Dom\u00ednguez-Berj\u00f3n","year":"2008","journal-title":"Gac. Sanit."},{"key":"B8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jamainternmed.2018.6989","article-title":"County-Level Opioid Prescribing in the United States, 2015 and 2017","volume":"179","author":"Guy","year":"2019","journal-title":"JAMA Intern Med."},{"key":"B9","first-page":"1","article-title":"Drug Overdose Deaths in the United States, 1999-2018","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3390\/jcm8122148","article-title":"The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 2018","volume":"8","author":"Herrera-G\u00f3mez","year":"2019","journal-title":"J. Clin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/bcp.13564","article-title":"Trends in Analgesic Consumption in France over the Last 10 Years and Comparison of Patterns across Europe","volume":"84","author":"Hider-Mlynarz","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"612556","DOI":"10.3389\/fphar.2020.612556","article-title":"Increasing Trends in Opioid Use from 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study","volume":"11","author":"Hurtado","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2468-2667(19)30128-8","article-title":"Trends in Use and Misuse of Opioids in the Netherlands: A Retrospective, Multi-Source Database Study","volume":"4","author":"Kalkman","year":"2019","journal-title":"Lancet Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2147\/JPR.S163438","article-title":"Do laws Impact Opioids Consumption? A Breakpoint Analysis Based on Italian Sales Data","volume":"11","author":"Musazzi","year":"2018","journal-title":"J. Pain Res."},{"key":"B15","first-page":"211","article-title":"Comparison of Confidence Intervals for the Poisson Mean: Some New Aspects","volume":"10","author":"Patil","year":"2012","journal-title":"REVSTAT Stat. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1192\/j.eurpsy.2021.2219","article-title":"Is Europe Facing an Opioid Crisis like the United States? An Analysis of Opioid Use and Related Adverse Effects in 19 European Countries between 2010 and 2018","volume":"64","author":"Pierce","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/CLEP.S186590","article-title":"Epidemiology of Dementia: Prevalence and Incidence Estimates Using Validated Electronic Health Records from Primary Care","volume":"11","author":"Ponjoan","year":"2019","journal-title":"Clin. Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.recesp.2011.07.017","article-title":"Validity for Use in Research on Vascular Diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA Study","volume":"65","author":"Ramos","year":"2012","journal-title":"Rev. Esp. Cardiol. Engl. Ed."},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","article-title":"Variation in Adult Outpatient Opioid Prescription Dispensing by Age and Sex - United States, 2008-2018","volume":"69","author":"Schieber","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular Effects and Safety of (Non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","article-title":"Cardiovascular Safety of Non-aspirin Non-steroidal Anti-inflammatory Drugs: Review and Position Paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"37","author":"Schmidt","year":"2016","journal-title":"Eur. Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/acr.23710","article-title":"Risk Factors for Low Back Pain: A Population-Based Longitudinal Study","volume":"71","author":"Shiri","year":"2019","journal-title":"Arthritis Care Res. Hob."},{"key":"B23","doi-asserted-by":"publisher","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular Safety of Non-steroidal Anti-inflammatory Drugs: Network Meta-Analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"B24","volume-title":"World Drug Report 2019","year":"2019"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jama.2021.15255","article-title":"Association of Tramadol vs Codeine Prescription Dispensation with Mortality and Other Adverse Clinical Outcomes","volume":"326","author":"Xie","year":"2021","journal-title":"JAMA"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.912361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T06:07:58Z","timestamp":1654668478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.912361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":25,"alternative-id":["10.3389\/fphar.2022.912361"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.912361","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"article-number":"912361"}}